30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Les Tari

Insider profile

Currently holds a position at Cidara Therapeutics Inc

Performance

Overall performance
3.6

Performance over holding periods
3.6
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 68% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Vice President - Discovery Research Cidara Therapeutics Inc None -

Les Tari's trades of Cidara Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-13 2025-03-11 PlS Planned sale
44,210 +40.2%
314.23
US$2,688,322
44,210 +40.2% 314.23 US$2,688,322
2024-09-13 2024-09-11 PlS Planned sale
83,265 +12.0%
285.75
US$3,003,919
83,265 +12.0% 285.75 US$3,003,919
2024-03-12 2024-03-11 PlS Planned sale
56,849 +7.9%
182.92
US$3,657,389
56,849 +7.9% 182.92 US$3,657,389
2023-09-13 2023-09-11 S Sale
18,469 -6.3%
0.95
US$17,509
18,469 -6.3% 0.95 US$17,509
2023-08-14 2023-08-14 PP Planned purchase
10,000 +3.5%
0.97
US$9,700
10,000 +3.5% 0.97 US$9,700
2023-03-13 2023-03-13 S Sale
7,562 -3.8%
1.53
US$11,570
7,562 -3.8% 1.53 US$11,570
2023-01-27 2023-01-12 S Sale
11,814 -88.8%
1.20
US$14,177
11,814 -88.8% 1.20 US$14,177
2022-09-13 2022-09-12 PlS Planned sale
18,159 -8.6%
0.68
US$12,437
18,159 -8.6% 0.68 US$12,437
2022-01-07 2022-01-05 S Sale
1,252 -0.8%
1.25
US$1,565
1,252 -0.8% 1.25 US$1,565